Home Cart 0 Sign in  

[ CAS No. 1155-62-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1155-62-0
Chemical Structure| 1155-62-0
Structure of 1155-62-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1155-62-0 ]

Related Doc. of [ 1155-62-0 ]

Alternatived Products of [ 1155-62-0 ]

Product Details of [ 1155-62-0 ]

CAS No. :1155-62-0 MDL No. :MFCD00002801
Formula : C13H15NO6 Boiling Point : -
Linear Structure Formula :- InChI Key :PVFCXMDXBIEMQG-JTQLQIEISA-N
M.W : 281.26 Pubchem ID :70866
Synonyms :
N-Carbobenzoxy-L-glutamic acid
Chemical Name :Z-Glu-OH

Calculated chemistry of [ 1155-62-0 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.31
Num. rotatable bonds : 9
Num. H-bond acceptors : 6.0
Num. H-bond donors : 3.0
Molar Refractivity : 68.27
TPSA : 112.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.99
Log Po/w (XLOGP3) : 0.92
Log Po/w (WLOGP) : 1.08
Log Po/w (MLOGP) : 0.82
Log Po/w (SILICOS-IT) : 0.55
Consensus Log Po/w : 0.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.79
Solubility : 4.55 mg/ml ; 0.0162 mol/l
Class : Very soluble
Log S (Ali) : -2.88
Solubility : 0.373 mg/ml ; 0.00133 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.15
Solubility : 2.01 mg/ml ; 0.00714 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.84

Safety of [ 1155-62-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1155-62-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1155-62-0 ]
  • Downstream synthetic route of [ 1155-62-0 ]

[ 1155-62-0 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 67-56-1 ]
  • [ 57933-83-2 ]
  • [ 1155-62-0 ]
  • [ 4652-65-7 ]
  • [ 5672-83-3 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
[2] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
  • 2
  • [ 1155-62-0 ]
  • [ 79-22-1 ]
  • [ 4652-65-7 ]
  • [ 5672-83-3 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
[2] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
  • 3
  • [ 1155-62-0 ]
  • [ 4652-65-7 ]
Reference: [1] Journal of the Chemical Society, 1950, p. 1954,1958
  • 4
  • [ 1155-62-0 ]
  • [ 79640-72-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 3, p. 956 - 968
  • 5
  • [ 1155-62-0 ]
  • [ 5891-45-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 3, p. 956 - 968
[2] Journal of Medicinal Chemistry, 1990, vol. 33, # 2, p. 461 - 464
  • 6
  • [ 67-56-1 ]
  • [ 57933-83-2 ]
  • [ 1155-62-0 ]
  • [ 4652-65-7 ]
  • [ 5672-83-3 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
[2] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
  • 7
  • [ 1155-62-0 ]
  • [ 79-22-1 ]
  • [ 4652-65-7 ]
  • [ 5672-83-3 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
[2] Tetrahedron Letters, 1987, vol. 28, # 15, p. 1665 - 1668
  • 8
  • [ 1155-62-0 ]
  • [ 5672-83-3 ]
Reference: [1] Tetrahedron Letters, 2001, vol. 42, # 37, p. 6603 - 6606
[2] Tetrahedron Letters, 1988, vol. 29, # 18, p. 2231 - 2234
[3] Tetrahedron Letters, 1984, vol. 25, # 14, p. 1425 - 1428
[4] Journal of the Chemical Society, 1950, p. 1954,1958
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 6, p. 2466 - 2477
  • 9
  • [ 1155-62-0 ]
  • [ 77-78-1 ]
  • [ 5672-83-3 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1972, p. 1 - 4
[2] Recueil des Travaux Chimiques des Pays-Bas, 1964, vol. 83, p. 199 - 207
  • 10
  • [ 1155-62-0 ]
  • [ 3886-08-6 ]
Reference: [1] Tetrahedron Letters, 1989, vol. 30, # 49, p. 6859 - 6860
  • 11
  • [ 1155-62-0 ]
  • [ 100-51-6 ]
  • [ 3705-42-8 ]
Reference: [1] ChemBioChem, 2012, vol. 13, # 9, p. 1319 - 1326
  • 12
  • [ 1155-62-0 ]
  • [ 3705-42-8 ]
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 16, p. 1604 - 1606
  • 13
  • [ 1155-62-0 ]
  • [ 100-39-0 ]
  • [ 3705-42-8 ]
Reference: [1] Journal of the Chemical Society [Section] C: Organic, 1967, p. 2410 - 2421
[2] Recueil des Travaux Chimiques des Pays-Bas, 1964, vol. 83, p. 199 - 207
  • 14
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 2, p. 461 - 464
[2] Tetrahedron, 1989, vol. 45, # 23, p. 7459 - 7468
[3] Journal of Medicinal Chemistry, 1991, vol. 34, # 3, p. 956 - 968
  • 15
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
[2] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 16
  • [ 1003-09-4 ]
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 17
  • [ 109-65-9 ]
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 18
  • [ 2398-37-0 ]
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 19
  • [ 111-25-1 ]
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 20
  • [ 100-59-4 ]
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 21
  • [ 591-51-5 ]
  • [ 4124-76-9 ]
  • [ 1155-62-0 ]
  • [ 32159-21-0 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 22
  • [ 1155-62-0 ]
  • [ 81470-51-1 ]
Reference: [1] Tetrahedron, 1989, vol. 45, # 23, p. 7459 - 7468
[2] Journal of Medicinal Chemistry, 1991, vol. 34, # 3, p. 956 - 968
[3] Journal of Medicinal Chemistry, 1990, vol. 33, # 2, p. 461 - 464
  • 23
  • [ 24424-99-5 ]
  • [ 1155-62-0 ]
  • [ 81470-51-1 ]
Reference: [1] Tetrahedron Asymmetry, 2006, vol. 17, # 14, p. 2120 - 2125
  • 24
  • [ 1155-62-0 ]
  • [ 24666-56-6 ]
Reference: [1] Patent: CN108218833, 2018, A,
  • 25
  • [ 1155-62-0 ]
  • [ 38101-59-6 ]
Reference: [1] ChemBioChem, 2012, vol. 13, # 9, p. 1319 - 1326
  • 26
  • [ 1155-62-0 ]
  • [ 62234-40-6 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1988, vol. 97, # 2, p. 135 - 148
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 1155-62-0 ]

Oglufanide Related Intermediates

Chemical Structure| 3705-42-8

[ 3705-42-8 ]

Z-Glu-OBzl

Related Functional Groups of
[ 1155-62-0 ]

Amino Acid Derivatives

Chemical Structure| 218938-55-7

[ 218938-55-7 ]

(S)-2-(((Benzyloxy)carbonyl)amino)-6-(isopropylamino)hexanoic acid

Similarity: 0.98

Chemical Structure| 25341-42-8

[ 25341-42-8 ]

(S)-2-(((Benzyloxy)carbonyl)amino)-3-cyclohexylpropanoic acid

Similarity: 0.98

Chemical Structure| 27025-24-7

[ 27025-24-7 ]

(R)-2-(((Benzyloxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid

Similarity: 0.98

Chemical Structure| 28862-79-5

[ 28862-79-5 ]

Z-D-Leu-OH

Similarity: 0.98

Chemical Structure| 4652-65-7

[ 4652-65-7 ]

Z-Glu(OMe)-OH

Similarity: 0.98